Psoriasis-like cutaneous inflammation in mice lacking interleukin-1 receptor antagonist

被引:90
|
作者
Shepherd, J [1 ]
Little, MC [1 ]
Nicklin, MJH [1 ]
机构
[1] Univ Sheffield, Royal Hallamshire Hosp, Div Genom Med, Sheffield, S Yorkshire, England
关键词
chronic disease; mice; knockout; inflammation; interleukin; 1;
D O I
10.1111/j.0022-202X.2004.22305.x
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Interleukin-1 receptor antagonist-deficient (II1rn-/-) BALB/c mice developed inflammation localized to the skin of the ear pinna in 64% of the cases examined. Histopathologically, the disease had many features resembling human psoriasis, suggesting that it might be a useful disease model. The epidermis became thickened and hypertrophic, and expressed the immature keratin, K6, throughout. The stratum corneum showed parakeratotsis. Large epidermal projections formed into a grossly thickened dermis and both tissues were infiltrated by leukocytes. Neutrophil-rich microabscesses formed beneath the stratum corneum. Dendritic cells and activated T cells of both helper classes were identified in both the dermis and epidermis, while a high density of macrophages was seen in the dermis, where mast cells were also prominent. Dense patterns of apparently activated small dermal vessels were seen in the diseased dermis. Cutaneous inflammation, along with arterial inflammation and arthritis, is the third site-specific, inflammatory disease to be found to affect II1rn-/- BALB/c mice. None of the diseases affected II1rn-/- C57BL/6. In F2 hybrids of II1rn-/- BALB/c and C57BL/6, cutaneous inflammation was absent, aortic inflammation was common, and arthritis was rare, indicating that the sets of background modifier genes that cause susceptibility to each disease are not fully overlapping.
引用
收藏
页码:665 / 669
页数:5
相关论文
共 50 条
  • [21] Exaggerated IL-23-induced psoriasis-like inflammation in mice lacking CCR4
    Hedrick, Michael
    Zhang, Hongwei
    Farber, Joshua
    JOURNAL OF IMMUNOLOGY, 2010, 184
  • [22] TNF-α Receptor 1 Antagonist Treatment Attenuates Arterial Inflammation and Intimal Hyperplasia in Interleukin-1 Receptor Antagonist Deficient Mice
    Isoda, Kikuo
    Kitagaki, Manabu
    Kamada, Haruhiko
    Tsunoda, Shinichi
    Tsutsumi, Yasuo
    Niida, Tomiharu
    Ishigami, Norio
    Ishihara, Miya
    Kikuchi, Makoto
    Ohsuzu, Fumitaka
    CIRCULATION, 2010, 122 (21)
  • [23] Graves' ophthalmopathy and gene polymorphisms in interleukin-1α, interleukin-1β, interleukin-1 receptor and interleukin-1 receptor antagonist
    Khalilzadeh, Omid
    Anvari, Mehdi
    Esteghamati, Alireza
    Mahmoudi, Mahdi
    Tahvildari, Maryam
    Rashidi, Armin
    Khosravi, Farideh
    Amirzargar, Aliakbar
    CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2009, 37 (06): : 614 - 619
  • [24] An Overview of Interleukin-1 Receptor Antagonist, Anakinra, in the Treatment of Cutaneous Diseases
    Pazyar, Nader
    Feily, Amir
    Yaghoobi, Reza
    CURRENT CLINICAL PHARMACOLOGY, 2012, 7 (04): : 271 - 275
  • [25] EMBRYONIC IMPLANTATION IN MICE IS BLOCKED BY INTERLEUKIN-1 RECEPTOR ANTAGONIST
    SIMON, C
    FRANCES, A
    PIQUETTE, GN
    ELDANASOURI, I
    ZURAWSKI, G
    DANG, W
    POLAN, ML
    ENDOCRINOLOGY, 1994, 134 (02) : 521 - 528
  • [26] Interleukin-17 receptor D constitutes an alternative receptor for interleukin-17A important in psoriasis-like skin inflammation
    Su, Yang
    Huang, Jinling
    Zhao, Xiaohong
    Lu, Huiping
    Wang, Wang
    Yang, Xuexian O.
    Shi, Yuling
    Wang, Xiaohu
    Lai, Yuping
    Dong, Chen
    SCIENCE IMMUNOLOGY, 2019, 4 (36)
  • [27] THE INTERLEUKIN-1 AXIS AND CUTANEOUS INFLAMMATION
    KUPPER, TS
    GROVES, RW
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1995, 105 (01) : S62 - S66
  • [28] Tumor Necrosis Factor Receptor Signaling in Keratinocytes Triggers Interleukin-24-Dependent Psoriasis-like Skin Inflammation in Mice
    Kumari, Snehlata
    Bonnet, Marion C.
    Ulvmar, Maria H.
    Wolk, Kerstin
    Karagianni, Niki
    Witte, Ellen
    Uthoff-Hachenberg, Claudia
    Renauld, Jean-Christophe
    Kollias, George
    Toftgard, Rune
    Sabat, Robert
    Pasparakis, Manolis
    Haase, Ingo
    IMMUNITY, 2013, 39 (05) : 899 - 911
  • [29] A Functional Interleukin-1 Receptor Antagonist Polymorphism Influences Atherosclerosis Development - The Interleukin-1β:Interleukin-1 Receptor Antagonist Balance in Atherosclerosis -
    Olofsson, Peder S.
    Sheikine, Yuri
    Jatta, Ken
    Ghaderi, Mehran
    Samnegard, Ann
    Eriksson, Per
    Sirsjoe, Allan
    CIRCULATION JOURNAL, 2009, 73 (08) : 1531 - 1536
  • [30] Effects of treatment with interleukin-1 receptor antagonist on endogenous interleukin-1 levels in normal and irradiated mice
    Bugarski, D
    Jovcic, G
    Kataranovski, M
    Ivanovic, Z
    Petakov, M
    Stojanovic, N
    Milenkovic, P
    PHYSIOLOGICAL RESEARCH, 2000, 49 (03) : 355 - 362